Literature DB >> 9806021

Incidence of hepatitis B virus infection in the United States, 1976-1994: estimates from the National Health and Nutrition Examination Surveys.

P J Coleman1, G M McQuillan, L A Moyer, S B Lambert, H S Margolis.   

Abstract

Precise estimates of the incidence of hepatitis B virus (HBV) infection are required to assess the impact of immunization and other prevention strategies in the United States. Race- and age-specific prevalence data obtained from the second and third National Health and Nutrition Examination Surveys (NHANES II, 1976-1980, and NHANES III, 1988-1994) were used to estimate the annual incidence of HBV infection by catalytic modeling. During the period covered by NHANES II, an estimated 323,462 persons were infected annually, and 334,863 were infected annually during the period covered by NHANES III. No statistically significant declines in prevalence of HBV infection occurred between the two surveys, a period during which hepatitis B vaccination targeted only limited numbers of high-risk adults.

Entities:  

Mesh:

Year:  1998        PMID: 9806021     DOI: 10.1086/515696

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  28 in total

Review 1.  Understanding correlates of hepatitis B virus vaccination in men who have sex with men: what have we learned?

Authors:  L J Yee; S D Rhodes
Journal:  Sex Transm Infect       Date:  2002-10       Impact factor: 3.519

Review 2.  Increasing immunization rates among African-American adults.

Authors: 
Journal:  J Natl Med Assoc       Date:  2003-04       Impact factor: 1.798

3.  Immunization needs of chronic liver disease patients seen in primary care versus specialist settings.

Authors:  R Jake Jacobs; Allen S Meyerhoff; Sammy Saab
Journal:  Dig Dis Sci       Date:  2005-08       Impact factor: 3.199

4.  Hepatitis B and C viral infections among blood donors from rural Ghana.

Authors:  B Nkrumah; M Owusu; H O Frempong; P Averu
Journal:  Ghana Med J       Date:  2011-09

5.  Characteristics of patients with chronic hepatitis-B virus infection in an urban hospital.

Authors:  David Widjaja; Suresh Yarlagadda; Bheema S Singu; Raghu S Loganathan; Steve Blum; Alan Bloom; Prospere Remy
Journal:  J Natl Med Assoc       Date:  2007-04       Impact factor: 1.798

6.  Surveillance programs for chronic viral hepatitis in three health departments.

Authors:  Douglas T Fleming; Amy Zambrowski; Felicia Fong; Andrea Lombard; Lynne Mercedes; Claudia Miller; Jan Poujade; Aaron Roome; Amy Sullivan; Lyn Finelli
Journal:  Public Health Rep       Date:  2006 Jan-Feb       Impact factor: 2.792

7.  Immunogenicity in humans of an edible vaccine for hepatitis B.

Authors:  Yasmin Thanavala; Martin Mahoney; Sribani Pal; Adrienne Scott; Liz Richter; Nachimuthu Natarajan; Patti Goodwin; Charles J Arntzen; Hugh S Mason
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-22       Impact factor: 11.205

8.  Healthy People 2010 and Asian Americans/Pacific Islanders: defining a baseline of information.

Authors:  Chandak Ghosh
Journal:  Am J Public Health       Date:  2003-12       Impact factor: 9.308

9.  Alanine aminotransferase decreases with age: the Rancho Bernardo Study.

Authors:  Mamie H Dong; Ricki Bettencourt; Elizabeth Barrett-Connor; Rohit Loomba
Journal:  PLoS One       Date:  2010-12-08       Impact factor: 3.240

10.  An economic assessment of pre-vaccination screening for hepatitis A and B.

Authors:  R Jake Jacobs; Sammy Saab; Allen S Meyerhoff; Raymond S Koff
Journal:  Public Health Rep       Date:  2003 Nov-Dec       Impact factor: 2.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.